Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Athersys

Athersys
1995 FOUNDED
PUBLIC STATUS
71-80 EMPLOYEES
ATHX STOCK SYMBOL
$1.34 SHARE PRICE (As of Friday Closing)
Description

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 3201 Carnegie Avenue
  • Cleveland, OH 44115
  • United States

+1 (216) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Athersys’s full profile, request a free trial.

Athersys Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.20 - $2.15 $205M $1.38 -$0.30 506K 153M

Athersys Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 200,606 156,147 186,312 111,434
Revenue 9,541 24,291 3,708 17,347
EBITDA (42,885) (23,428) (31,557) (14,992)
Net Income (43,705) (24,283) (32,241) (15,337)
Total Assets 53,247 61,730 33,593 19,060
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Athersys Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Athersys‘s full profile, request access.

Request full access to PitchBook

Athersys Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Baliopharm Corporate Backed or Acquired Basel, Switzerland 000000&0
000000000 00000000 Corporation Basking Ridge, NJ 00 00000 000000000 00000
00000000 000000000 Formerly VC-backed Beverly Hills, CA 00 000.00 000000000 000.00
0000000 0000000000 Venture Capital-Backed San Diego, CA 0 0000 00000000000 0000
0000000000 0000000 Formerly VC-backed San Diego, CA 000 000000&0
To view this company’s complete list of competitors, request access »

Athersys Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Athersys‘s full profile, request access.

Request full access to PitchBook

Athersys Executive Team (8)

Name Title Board
Seat
Contact
Info
Gil Van Bokkelen Ph.D Chief Executive Officer & Chairman
William Lehmann Jr. Chief Operating Officer & President
Laura Campbell Chief Financial Officer & Chief Accounting Officer
John Harrington Ph.D Chief Scientific Officer & Founder
Judy Hubbard Senior Director, Operations

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

Athersys Board Members (13)

Name Representing Role Since Contact
Info
000 000 00000000 00.0 Athersys Chief Executive Officer & Chairman 000 0000
000000 0000 00.0 Self Board Member 000 0000
0000 000000000000 Self Board Member 000 0000
0000 0000000 Self Board Member 000 0000
000 000000 00.0 Self Board Member 000 0000

7 Former Board Members

You’re viewing 5 of 13 board members. Get the full list »